Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 6, 2010, Pages 2928-2935

  Peiretti, Enrico ^a   Mandas, Antonella ^b   Cocco, Pierluigi ^a   Norfo, Claudia ^a   Abete, Claudia ^a   Angius, Fabrizio ^a   Pani, Alessandra ^a   Vascellari, Sarah ^a   del Fiacco, Guido ^a   Cannas, Dolores ^a   Diaz, Giacomo ^a   Dessì, Sandra ^b   Fossarello, Maurizio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Departments of Internal Medical Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; MESSENGER RNA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CELL GROWTH; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GROWTH RATE; HUMAN; HUMAN CELL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PTERYGIUM; RISK FACTOR; ADOLESCENT; CELL SURVIVAL; CONJUNCTIVA; CYTOLOGY; ENZYMOLOGY; ERYTHROCYTE MEMBRANE; GENETICS; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CELL SURVIVAL; CHOLESTEROL; CONJUNCTIVA; ERYTHROCYTE MEMBRANE; FEMALE; FIBROBLASTS; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PTERYGIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 77953269970     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4426     Document Type: Article

References (38)

1. Beutler E. Glucose 6-phosphate dehydrogenase. In: Stanbury JB, Wyngaarden JB, Fredrickson DJ, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Disease. NewYork: McGraw-Hill; 1983;1629-1653.
2. Kruger NJ, von Schaewen A. The oxidative pentose phosphate pathway: structure and organisation. Curr Opin Plant Biol. 2003; 6(3):236-246.
3. Burak Çimen MY. Free radical metabolism in human erythrocytes. Clin Chim Acta. 2008;390:1-11.
4. Fico A, Paglialunga F, Cigliano L, et al. Glucose-6-phosphate dehydrogenase plays a crucial role in the protection from redox-stress induced apoptosis. Cell Death Differ. 2004;11:823-831.
5. Veech RL. A humble hexose monophosphate pathway metabolite regulates short- and long-term control of lipogenesis, Proc Natl Acad Sci USA. 2003;100(10):5578-5580.
6. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog. 1992;3:91-115.
7. Luzzatto L, Battistuzzi G. Glucose-6-phosphate dehydrogenase variants. Adv Hum Genet. 1985;14:217-329.
8. Fenu MP, Finazzi G, Manoussakis C, Palomba V, Fiorelli G. Glucose- 6-phosphate dehydrogenase deficiency: genetic heterogeneity in Sardinia. Ann Hum Genet. 1982;46:105-114.
9. Luzzatto L, Mehta A, Vulliamy T. Glucose-6-phosphate dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, eds. The Metabolic Basis of Inherited Disease. Vol 3. New York: McGraw- Hill; 2001;4517-4553.
10. De Vita G, Alcalay M, Sampietro M. Cappelini D, Fiorelli G, Toniolo D. Two point mutations are responsible for G6PD polymorphism in Sardinia. Am J Hum Genet. 1989;44:233-240.
11. Huang Y, Choi MY, Au Ngor Wing S, et al. Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PDPlymouth and G6PDMahidol: evidence for defective protein folding as the basis of disease. Mol Genet Metab. 2008;93:44-53.
12. Keller DF, Kellermeyer RW. Erythrocyte glucose-6-phosphate dehydrogenase deficiency a pharmacogenetic prototype. Crit Rev Clin Lab Sci. 1970;1:247-302.
13. Dessì S, Batetta B, Cherchi R, Onnis R, Pisano M, Pani P. Hexose monophosphate shunt enzymes in lung tumors from normal and glucose-6-phosphate-dehydrogenase-deficient subjects. Oncology. 1988;45:287-291.
14. Batetta B, Pulisci D, Bonatesta RR, et al. G6PD activity and gene expression in leukemic cells from G6PD-deficient subjects. Cancer Lett. 1999;140:53-58.
15. Sulis E. G-6-PD deficiency and cancer. Lancet. 1972;1(7761):1185.
16. Meloni L, Manca MR, Loddo I, et al. Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease. J Inherit Metab Dis. 2008;31:412-417.
17. Forteleoni G, Argiolas L, Farris A, Ferraris AM, Gaetani GF, Meloni T. G6PD deficiency and breast cancer. Tumori. 1988;74:665-667.
18. Cocco P, Dessí S, Avataneo G, Picchiri G, Heinemann E. Glucose- 6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case-control study. Carcinogenesis. 1989;10: 813-816.
19. Cocco P, Todde P, Fornera S, Manca MB, Manca P, Sias AR. Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood. 1998;91:706-709.
20. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288.
21. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol. 1999;128:280-287.
22. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis. Arch Ophthalmol. 2001;119:695-706.
23. Cheng ML, Ho HY, Wu YH, Chiu DT. Glucose-6-phosphate dehydrogenase- deficient cells show an increased propensity for oxidant- induced senescence. Free Radic Biol Med. 2004;36(5):580-591.
24. Peiretti E, Dessì S, Mulas MF, Abete C, Galantuomo MS, Fossarello M. Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics. Exp Eye Res. 2006;83:536-542.
25. Peiretti E, Dessì S, Mulas C, et al. Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest Ophthalmol Vis Sci. 2007;48:3450-3458.
26. Peiretti E, Dessì S, Putzolu M, Fossarello M. Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary pterygium. Invest Ophthalmol Vis Sci. 2004;45:3982-3985.
27. Beutler E. Red Cell Metabolism Manual of Biochemical Methods. London: Academic Press; 1971;68-70.
28. Diaz G, Batetta B, Sanna F, et al. Lipid droplet changes in proliferating and quiescent 3T3 fibroblasts. Histochem Cell Biol. 2008; 129:611-621.
29. Bidlack WR, Tappel AL. Fluorescent products of phospholipids during lipid peroxidation. Lipids. 1973;8:203-207.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
31. Orzalesi N, Fossarello M, Sorcinelli R, Schlich U. The relationship between glucose-6-phosphate deficiency and cataracts in Sardinia: an epidemiologic and biochemical study. Doc Ophthalmol. 1984; 57:187-201.
32. Chen J-K, Tsai RJF, Lin S-S. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol. 1994;30:243-248.
33. Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors innude mice. Int J Cancer. 2000;85(6):857-864.
34. Armstrong JS, Steinauer KK, Hornung B, et al. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ. 2002;9:252-263.
35. Martini G, Ursini MV. A new lease of life for an old enzyme. Bioessays. 1996;18:631-637.
36. Okada F. Beyond foreign-body-induced carcinogenesis: impact of reactive oxygen species derived from inflammatory cells in tumorigenic conversion and tumor progression. Int J Cancer. 2007;121: 2364-2372.
37. Yoon SO, Chang HY, Chung AS. Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev. 2002;123:1597-1604.
38. Trosko JE, Chang CC. Hallmarks of radiation carcinogenesis: ignored concepts. International Congress Series. 2003;1258:31-36.